MedPath

陕西西岳制药有限公司

Ownership
-
Established
1992-11-08
Employees
-
Market Cap
-
Website
http://www.xiyuezy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

58

NMPA:58

Drug Approvals

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H20064672
Approval Date
Mar 31, 2022
NMPA

Nitrofurantoin Enteric-coated Tablets

Product Name
呋喃妥因肠溶片
Approval Number
国药准字H20064736
Approval Date
Mar 31, 2022
NMPA

Isoniazid Tablets

Product Name
异烟肼片
Approval Number
国药准字H20064684
Approval Date
Mar 31, 2022
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H20064398
Approval Date
Mar 31, 2022
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H20064714
Approval Date
Mar 31, 2022
NMPA

Calcium Gluconate Tablets

Product Name
葡萄糖酸钙片
Approval Number
国药准字H20064674
Approval Date
Mar 31, 2022
NMPA

Levamisole Hydrochloride Tablets

Product Name
盐酸左旋咪唑片
Approval Number
国药准字H20064690
Approval Date
Mar 31, 2022
NMPA

Aluminium Hydroxide Tablets

Product Name
氢氧化铝片
Approval Number
国药准字H20064675
Approval Date
Feb 10, 2022
NMPA

Vitamin B2 Tablets

Product Name
维生素B2片
Approval Number
国药准字H20064678
Approval Date
Feb 10, 2022
NMPA

Saccharated Yeast Tablets

Product Name
食母生片
Approval Number
国药准字H20064676
Approval Date
Feb 10, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.